Corbus Pharmaceuticals Holdings, Inc. (CRBP) revenue

Revenue · fiscal 2021
$881.71K

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported revenue of $881.71K in fiscal 2021 (the year ended December 31, 2021). That is 77.6% lower than the $3.94M of fiscal 2020. Figures as of 18 Nov 2026, 12:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2021
$881.71K
Change on fiscal 2020
−77.6%
Growth, 5 years
−14.3% a year
Highest on record
$36.14Mfiscal 2019
Lowest on record
$648.38Kfiscal 2015
Fiscal years on record
72015–2021

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corbus Pharmaceuticals Holdings, Inc. revenue, in more detail

Over the five fiscal years to 2021 revenue shrank at a compound 14.3% a year. Across the 7 fiscal years on record (2015–2021), the highest was $36.14M in fiscal 2019 and the lowest $648.38K in fiscal 2015.

History · 7 fiscal years

Revenue by fiscal year

Corbus Pharmaceuticals Holdings, Inc. revenue, year by year

Corbus Pharmaceuticals Holdings, Inc. (CRBP) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2021$881.71K 77.6% down
2020$3.94M 89.1% down
2019$36.14M 649.5% up
2018$4.82M 97.6% up
2017$2.44M 27.7% up
2016$1.91M 194.8% up
2015$648.38K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on CRBP

Corbus Pharmaceuticals Holdings, Inc., figure by figure

Corbus Pharmaceuticals Holdings, Inc. (CRBP) overview: price, valuation and scorecard

Corbus Pharmaceuticals Holdings, Inc. revenue: questions and answers

What is Corbus Pharmaceuticals Holdings, Inc.'s revenue?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported revenue of $881.71K in fiscal 2021 (the year ended December 31, 2021). That is 77.6% lower than the $3.94M of fiscal 2020.

What is the growth rate of Corbus Pharmaceuticals Holdings, Inc.'s revenue?

Over the five fiscal years to 2021 revenue shrank at a compound 14.3% a year.

What are the highest and lowest revenue figures on record for Corbus Pharmaceuticals Holdings, Inc.?

Across the 7 fiscal years on record (2015–2021), the highest was $36.14M in fiscal 2019 and the lowest $648.38K in fiscal 2015.

How is Corbus Pharmaceuticals Holdings, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Corbus Pharmaceuticals Holdings, Inc. it is on record here for 7 fiscal years, 2015 to 2021.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corbus Pharmaceuticals Holdings, Inc. (CRBP) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/CRBP/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.